LYGEN (CHLORDIAZEPOXIDE HYDROCHLORIDE) — FDA Approval ANDA085009 (ALRA)
LYGEN (CHLORDIAZEPOXIDE HYDROCHLORIDE) — FDA Approval ANDA085009 (ALRA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: LYGEN; Active ingredients: CHLORDIAZEPOXIDE HYDROCHLORIDE; Application number: ANDA085009.
| Brand name | LYGEN |
|---|---|
| Active ingredients | CHLORDIAZEPOXIDE HYDROCHLORIDE |
| Application number | ANDA085009 |
| Sponsor | ALRA |
| Dosage form | CAPSULE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19760421 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →